PADI4 and neoplasm: GSK484 treatment promoted tumor cell radiosensitivity, induced cell death by promoting DNA double-strand breaks, inhibited the effects of PAD4 overexpression in irradiated cells, and inhibited the formation of NETs in vivo (139).